查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1881892

器官生理微系統市場報告：趨勢、預測與競爭分析（至2031年）

Organ Physiological Microsystem Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球器官和生理微系統市場預計將成為一個充滿前景的市場，這主要得益於製藥和生物技術公司以及學術和研究機構的機遇，預計從 2025 年到 2031 年，該市場將以 15% 的複合年成長率成長。關鍵成長要素包括對先進藥物測試模型的需求不斷成長、對個人化醫療研究的投資不斷增加，以及器官晶片技術在醫療保健領域的應用日益廣泛。

  • 根據 Lucintel 的預測，按類型分類，多器官系統預計在預測期內將呈現更高的成長率。
  • 從應用領域來看，製藥和生技公司預計將呈現更高的成長率。
  • 從區域來看，預計亞太地區在預測期內將達到最高的成長率。

器官生理微系統（模擬器官系統）市場的新興趨勢

器官生理微系統市場正經歷幾項重大的新興趨勢，這些趨勢正在從根本上重塑這個領域。這些趨勢推動著技術從簡單的器官模型向更複雜、整合和自動化的系統演進，從而為從藥物研發到個人化醫療等廣泛應用提供更準確、更具預測性的數據。

  • 多重器官系統的發展：一個顯著的趨勢是從單一器官晶片模型轉向整合多器官系統，或所謂的「人體晶片」系統。這些平台將不同的器官模型（例如肝臟、肺臟和心臟）連接起來，以模擬它們之間的相互作用。這有助於全面了解藥物的系統代謝、療效和潛在毒性，從而提供一個更全面、更具預測性的臨床前測試平台。
  • 先進感測器的整合：一種新興趨勢是將生物感測器和即時監測工具直接整合到晶片上。這些感測器可以即時測量各種生理參數，例如氧濃度、pH值和細胞電活動。這為研究人員提供了連續、高精度的數據，無需進行晶片外分析，從而提高了實驗結果的通量和可靠性。
  • 利用患者來源的誘導多能幹細胞：利用患者來源的誘導多功能細胞（iPS細胞）來建構器官模型是一項重要的研究趨勢。使用患者自身的細胞可以創建個人化的疾病模型，從而準確反映個體獨特的基因組成和生理反應。這代表著個人化醫療領域的突破，能夠促進客製化治療方法的開發和藥物篩檢。
  • 自動化與高通量篩檢：市場正朝向自動化、高通量的晶片外檢測（OOC）平台發展。各公司正在開發機器人系統和軟體來處理晶片負載、培養基交換和資料收集。這種自動化減少了人工勞動，最大限度地減少了人為錯誤，並實現了對大量化合物的同步篩檢，使OOC技術更具擴充性和實用性，更適用於製藥業。
  • 疾病建模與治療方法：利用體外器官系統（OOC）模擬特定人類疾病（包括神經系統疾病、癌症和感染疾病）的趨勢日益成長。研究人員正在利用這些系統在生理相關環境中研究疾病機制並測試新型治療化合物。這項應用對於加深我們對複雜疾病的理解以及加速新治療方法的研發至關重要。

這些趨勢正將OOC從一種小眾研究工具擴充性為一個先進、可擴展且高度預測性的平台，服務製藥和生物技術產業。研究重點正轉向開發更貼近實際、更整合、更個人化的模型，以彌合臨床前試驗和臨床試驗之間的差距。

器官生理微系統市場的最新趨勢

器官生理微系統市場正經歷多項關鍵發展，這些發展推動了技術進步並擴大了應用範圍。這些發展主要集中在提昇平台生理相關性、擴充性和預測能力，而這些對於平台在藥物開發和研發領域的更廣泛應用至關重要。

  • 先進的多器官系統：近期的一項重大進展是更先進的晶片多器官系統平台的開發和商業化。例如，一家公司推出了一種「腸-肝-腦」系統，使研究人員能夠同時研究藥物代謝及其神經系統效應。這項進步能夠更全面地展現藥物的系統性效應，並在毒性測試領域日益受到關注。
  • 新型材料和製造技術：用於製造這些晶片的材料正在取得重大進展。研究人員正在利用新型聚合物和生物材料，這些材料能夠更精確地模擬活體組織環境，並支持原代細胞的長期培養。這些材料創新提高了體外細胞培養（OOC）模型的生物學保真度和穩定性，從而獲得更可靠、更可重複的結果。
  • 人工智慧在數據分析中的應用：一項關鍵進展是將人工智慧 (AI) 和機器學習技術應用於分析 OOC 實驗產生的大量數據。 AI 演算法可以處理即時感測器數據和影像分析，從而識別細胞行為的細微變化，並更準確地預測藥物反應。這使得 OOC 平台在藥物篩檢更加強大和高效。
  • 標準化和檢驗工作：產業聯盟和監管機構正積極致力於標準化體外檢測（OOC）平台並制定檢驗指南。例如，一家生技公司與監管機構近期合作，旨在檢驗一個用於預測肝毒性的OOC模型。這項進展對於建立信任以及推動OOC數據在監管申報中獲得正式認可至關重要。
  • 拓展至臨床應用：儘管晶片腫瘤技術（OOC）主要用於臨床前研究，但如今它正逐步應用於臨床。近期案例包括利用患者來源的腫瘤晶片測試多種抗癌藥物，以確定對特定患者最有效的藥物，展現了該技術在個人化醫療領域的潛力。

這些進展正在透過加速技術的成熟和可靠性來影響市場。重點在於推動OOC平台從概念驗證階段過渡到檢驗和標準化的工具，從而促進其融入藥物開發和臨床工作流程，預計將節省時間和資源。

目錄

第1章執行摘要

第2章 市場概覽

  • 背景和分類
  • 供應鏈

第3章：市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球器官生理微系統市場（依類型分類）

  • 吸引力分析：按類型
  • 單一器官系統
  • 多重器官系統

第5章 全球器官生理微系統市場（依應用分類）

  • 吸引力分析：依目的
  • 製藥和生物技術公司
  • 學術和研究機構
  • 其他

第6章 區域分析

第7章 北美器官生理微系統市場

  • 北美器官生理微系統市場（按類型分類）
  • 北美器官生理微系統市場（依應用分類）
  • 美國器官生理微系統市場
  • 墨西哥器官生理微系統市場
  • 加拿大器官生理微系統市場

第8章 歐洲器官生理微系統市場

  • 歐洲器官生理微系統市場（按類型分類）
  • 歐洲器官生理微系統市場（依應用分類）
  • 德國器官生理微系統市場
  • 法國器官生理微系統市場
  • 西班牙器官生理微系統市場
  • 義大利器官生理微系統市場
  • 英國器官生理微系統市場

第9章 亞太地區器官生理微系統市場

  • 亞太地區器官生理微系統市場（依類型分類）
  • 亞太地區器官生理微系統市場（依應用分類）
  • 日本器官與生理顯微系統市場
  • 印度器官生理微系統市場
  • 中國器官生理微系統市場
  • 韓國器官生理微系統市場
  • 印尼器官生理微系統市場

第10章 其他地區（ROW）器官生理微系統市場

  • ROW器官生理微系統市場依類型分類
  • ROW器官生理微系統市場依應用領域分類
  • 中東器官生理微系統市場
  • 南美洲器官生理微系統市場
  • 非洲器官生理微系統市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
  • 市佔率分析

第12章：機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 全球器官生理微系統市場新興趨勢
  • 戰略分析

第13章：價值鏈中主要企業的概況

  • 競爭分析
  • Emulate
  • Draper Laboratory
  • Mimetas
  • TissUse
  • CN Bio
  • Hesperos
  • Nortis
  • Micronit
  • Kirkstall
  • Bi/ond

第14章附錄

The future of the global organ physiological microsystem market looks promising with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global organ physiological microsystem market is expected to grow with a CAGR of 15% from 2025 to 2031. The major drivers for this market are the increasing demand for advanced drug testing models, the rising investments in personalized medicine research, and the growing adoption of organ-on-chip technology in healthcare.

  • Lucintel forecasts that, within the type category, multi-organ system is expected to witness higher growth over the forecast period.
  • Within the application category, pharmaceutical & biotechnology company is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Organ Physiological Microsystem Market

The organ physiological microsystem market is experiencing several key emerging trends that are fundamentally reshaping the field. These trends are moving the technology beyond simple organ models to more complex, integrated, and automated systems that provide more accurate and predictive data for a range of applications, from drug discovery to personalized medicine.

  • Development of Multi-Organ Systems: A significant trend is the move from single-organ-on-a-chip models to integrated multi-organ or "human-on-a-chip" systems. These platforms connect different organ models, such as the liver, lung, and heart, to simulate organ-organ interactions. This enables a more comprehensive understanding of systemic drug metabolism, efficacy, and potential toxicity, providing a more holistic and predictive preclinical testing platform.
  • Integration of Advanced Sensors: An emerging trend is the integration of biosensors and real-time monitoring tools directly onto the chips. These sensors can measure various physiological parameters, such as oxygen levels, pH, and cellular electrical activity, in real-time. This provides researchers with continuous, high-fidelity data, eliminating the need for off-chip analysis and enhancing the throughput and reliability of experimental results.
  • Use of Patient-Derived iPSCs: The use of patient-derived induced pluripotent stem cells (iPSCs) to create organ models is a key trend. By using a patient's own cells, researchers can create personalized disease models that accurately reflect an individual's unique genetic makeup and physiological response. This is a game-changer for personalized medicine, enabling the development of tailored therapies and drug screening.
  • Automation and High-Throughput Screening: The market is seeing a push for automated and high-throughput OOC platforms. Companies are developing robotic systems and software to handle chip loading, media exchange, and data collection. This automation reduces manual labor, minimizes human error, and allows for the screening of a large number of compounds simultaneously, making OOC technology more scalable and practical for the pharmaceutical industry.
  • Disease Modeling and Therapeutics: A growing trend is the use of OOCs to model specific human diseases, such as neurological disorders, cancer, and infectious diseases. Researchers are using these systems to study disease mechanisms and test new therapeutic compounds in a physiologically relevant environment. This application is crucial for advancing our understanding of complex diseases and accelerating the development of new treatments.

These trends are reshaping the market by transforming OOCs from a niche research tool into a sophisticated, scalable, and highly predictive platform for the pharmaceutical and biotechnology industries. The focus is shifting towards creating more realistic, integrated, and personalized models that can bridge the gap between preclinical and clinical trials.

Recent Developments in the Organ Physiological Microsystem Market

The organ physiological microsystem market has seen several key developments that are advancing the technology and expanding its applications. These developments are focused on improving the physiological relevance, scalability, and predictive power of these platforms, which is crucial for their wider adoption in drug development and research.

  • Advanced Multi-Organ Systems: A major recent development is the creation and commercialization of more sophisticated multi-organ-on-a-chip platforms. For example, a company might launch a "gut-liver-brain" system that allows for the study of drug metabolism and its neurological effects simultaneously. This advancement provides a more complete picture of a drug's systemic impact and is gaining traction for toxicology testing.
  • Novel Materials and Fabrication: There have been significant developments in the materials used to create these chips. Researchers are using new polymers and biomaterials that better mimic the native tissue environment and support the long-term culture of primary cells. These material innovations are enhancing the biological fidelity and stability of OOC models, leading to more reliable and reproducible results.
  • AI Integration for Data Analysis: A key development is the integration of artificial intelligence (AI) and machine learning for analyzing the vast amount of data generated by OOC experiments. AI algorithms can process real-time sensor data and image analysis to identify subtle changes in cellular behavior and predict drug responses more accurately. This makes OOC platforms more powerful and efficient for drug screening.
  • Standardization and Validation Initiatives: Industry consortia and regulatory bodies are actively working on standardizing OOC platforms and establishing validation guidelines. For example, a recent collaboration between a biotech firm and a regulatory agency might aim to validate an OOC model for predicting liver toxicity. This development is crucial for building trust and enabling the formal acceptance of OOC data in regulatory submissions.
  • Expansion into Clinical Applications: While primarily used in preclinical research, OOC technology is now seeing its first clinical applications. A recent development could be a study using a patient-derived tumor-on-a-chip to test a panel of cancer drugs to determine which is most effective for that specific patient. This demonstrates the technology's potential for personalized medicine.

These developments are impacting the market by accelerating the technology's maturity and credibility. The focus is on moving OOC platforms from a proof-of-concept stage to a validated, standardized tool that is increasingly integrated into the drug development and clinical workflow, promising to save time and resources.

Strategic Growth Opportunities in the Organ Physiological Microsystem Market

The organ physiological microsystem market offers significant strategic growth opportunities by leveraging its unique ability to mimic human physiology. These opportunities are concentrated in high-value applications where OOC technology can provide a superior alternative to traditional models, thereby addressing critical needs in drug development and personalized healthcare.

  • Drug Discovery and Efficacy Testing: The most significant opportunity lies in replacing or complementing traditional animal models for drug discovery. OOCs can provide more human-relevant data on a drug's efficacy and mechanism of action early in the development process. This can help pharmaceutical companies to screen compounds more effectively, reducing the high rate of drug failure in clinical trials and saving billions in R&D costs.
  • Toxicology and Safety Assessment: OOC platforms offer a powerful tool for toxicology testing, particularly for organs like the liver, heart, and kidney. Companies can use these models to test for potential organ toxicity of new compounds in a controlled, human-relevant environment, which is a major regulatory requirement. This application is a key growth area, especially with the global push to reduce animal testing.
  • Personalized and Precision Medicine: A major strategic opportunity is the use of OOCs for personalized medicine. By using patient-derived cells, researchers can create "patient-on-a-chip" models to test which treatments are most effective for an individual. This can revolutionize the treatment of diseases like cancer, enabling doctors to select the best therapy and avoid ineffective or toxic drugs.
  • Disease Modeling and Pathogenesis Studies: OOC platforms are an excellent tool for modeling human diseases, from genetic disorders to infectious diseases. By recreating the physiological environment of a diseased organ, researchers can study disease progression and test new therapeutic strategies. This application is crucial for advancing our fundamental understanding of human biology and developing targeted treatments.
  • Cosmetics and Chemical Testing: The cosmetics and consumer goods industries present a significant growth opportunity due to a growing demand for cruelty-free and animal-free testing methods. OOC platforms can be used to test the safety of cosmetic ingredients and chemicals on a human-relevant model, ensuring product safety and meeting evolving consumer and regulatory expectations.

These growth opportunities are impacting the market by highlighting the technology's value proposition across multiple sectors. The focus is on transitioning OOCs from an academic tool to an essential, commercially viable platform that can address major bottlenecks in drug development, improve patient outcomes, and promote ethical testing practices.

Organ Physiological Microsystem Market Driver and Challenges

The organ physiological microsystem market is shaped by a confluence of technological, economic, and regulatory factors. The market's growth is primarily driven by the need for more efficient and ethical methods of drug testing, while its expansion is hindered by significant technical and commercial challenges that must be overcome for widespread adoption.

The factors responsible for driving the organ physiological microsystem market include:

1. Need for Predictive Human Models: The high failure rate of drugs in clinical trials, largely due to poor translation from animal models to humans, is a primary driver. OOC platforms offer a more physiologically relevant and predictive alternative, providing a better understanding of drug efficacy and toxicity in human-like systems before human trials.

2. Growing Focus on Personalized Medicine: The increasing demand for personalized medicine is a key driver. OOCs can be created using a patient's own cells, allowing for the testing of various drug therapies to determine the most effective treatment for that individual. This is a powerful tool for tailoring medicine to specific patients.

3. Reducing Animal Testing: There is a global push, driven by ethical concerns and regulatory changes, to reduce or replace animal testing. OOCs provide a viable alternative that can generate human-relevant data without the use of live animals, making them an attractive option for pharmaceutical, cosmetic, and chemical industries.

4. Technological Advancements: Continuous innovations in microfluidics, biomaterials, and cell culture techniques are driving the market forward. These advancements have enabled the creation of more complex and physiologically realistic OOC models, with integrated sensors and automation capabilities, making the technology more robust and scalable for industrial applications.

5. High Cost of Drug Discovery: The high cost and long timelines of traditional drug discovery are major drivers. By enabling earlier and more accurate screening of drug candidates, OOCs can help companies de-risk their R&D pipelines, reduce late-stage failures, and ultimately lower the overall cost of bringing a new drug to market.

Challenges in the organ physiological microsystem market are:

1. Standardization and Validation: A major challenge is the lack of standardized protocols and validation guidelines for OOC platforms. Variations in chip design, cell sources, and experimental procedures can lead to inconsistent results, making it difficult for regulatory bodies to accept the data and for the industry to adopt the technology on a large scale.

2. High Cost of Platforms: The high initial cost of OOC platforms, including the specialized instrumentation, consumables, and skilled personnel required to operate them, is a significant barrier to widespread adoption. This high cost can be prohibitive for smaller research labs and biotech startups.

3. Replicating Complex Human Physiology: Despite advancements, OOCs still struggle to fully replicate the complexity of the human body, including the immune system, endocrine signaling, and the intricate interaction of multiple organ systems. This limitation means they cannot completely replace animal models for all applications, posing a key challenge for their future growth.

The organ physiological microsystem market is driven by the urgent need for more predictive, cost-effective, and ethical drug development tools. However, its growth is constrained by the challenges of standardization, high costs, and the inherent difficulty of fully replicating human biological complexity. The market's future success depends on addressing these challenges to build trust and achieve widespread adoption.

List of Organ Physiological Microsystem Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies organ physiological microsystem companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the organ physiological microsystem companies profiled in this report include-

  • Emulate
  • Draper Laboratory
  • Mimetas
  • TissUse
  • CN Bio
  • Hesperos
  • Nortis
  • Micronit
  • Kirkstall
  • Bi/ond

Organ Physiological Microsystem Market by Segment

The study includes a forecast for the global organ physiological microsystem market by type, application, and region.

Organ Physiological Microsystem Market by Type [Value from 2019 to 2031]:

  • Single-organ System
  • Multi-organ System

Organ Physiological Microsystem Market by Application [Value from 2019 to 2031]:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Country Wise Outlook for the Organ Physiological Microsystem Market

The organ physiological microsystem market, encompassing technologies like Organ-on-a-Chip (OOC), is experiencing rapid growth as it revolutionizes drug discovery, toxicology, and personalized medicine. This market is driven by the urgent need for more predictive, human-relevant models that can reduce the reliance on animal testing and lower the high cost of drug development. These platforms offer a more accurate way to model human physiology and disease.

  • United States: The U.S. is a dominant player, with significant R&D investment from government agencies like the NIH and FDA, and major private sector funding. This has led to the development of advanced multi-organ chips and human-on-a-chip platforms. The focus is on integrating these systems into the drug development pipeline to improve the predictability of clinical trial outcomes and expedite the approval process for new therapies.
  • China: China is rapidly expanding its presence in the market, driven by substantial government investment in biotechnology and a growing life sciences sector. Researchers and companies are focused on developing their own OOC technologies, particularly for applications in disease modeling and toxicology testing. The country aims to reduce its reliance on international technologies and establish a strong domestic market.
  • Germany: Germany is a key hub for OOC technology in Europe, leveraging its strong expertise in biomedical engineering and microfluidics. The market is supported by a robust research ecosystem with collaborations between universities and biotech companies. The focus is on creating highly realistic organ models, with recent research efforts aimed at integrating vascular systems to improve the physiological relevance of these platforms.
  • India: India is emerging as a growth market, with increasing investment in biotechnology and a focus on cost-effective drug discovery and development. The market for OOCs is being driven by the need for alternatives to animal testing and a push for more efficient preclinical research. Academic institutions and startups are leading the development of indigenous OOC technologies.
  • Japan: Japan's market is characterized by a strong emphasis on regenerative medicine and advanced cell culture techniques. Researchers and companies are developing OOC models using human-induced pluripotent stem cells (iPSCs) to create patient-specific disease models. This focus on personalized medicine and regenerative therapies is a key driver for the adoption of sophisticated physiological microsystems.

Features of the Global Organ Physiological Microsystem Market

  • Market Size Estimates: Organ physiological microsystem market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Organ physiological microsystem market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Organ physiological microsystem market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the organ physiological microsystem market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the organ physiological microsystem market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the organ physiological microsystem market by type (single-organ system and multi-organ system), application (pharmaceutical & biotechnology companies, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Organ Physiological Microsystem Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Single-organ System: Trends and Forecast (2019-2031)
  • 4.4 Multi-organ System: Trends and Forecast (2019-2031)

5. Global Organ Physiological Microsystem Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pharmaceutical & Biotechnology Companies: Trends and Forecast (2019-2031)
  • 5.4 Academic & Research Institutes: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Organ Physiological Microsystem Market by Region

7. North American Organ Physiological Microsystem Market

  • 7.1 Overview
  • 7.2 North American Organ Physiological Microsystem Market by Type
  • 7.3 North American Organ Physiological Microsystem Market by Application
  • 7.4 United States Organ Physiological Microsystem Market
  • 7.5 Mexican Organ Physiological Microsystem Market
  • 7.6 Canadian Organ Physiological Microsystem Market

8. European Organ Physiological Microsystem Market

  • 8.1 Overview
  • 8.2 European Organ Physiological Microsystem Market by Type
  • 8.3 European Organ Physiological Microsystem Market by Application
  • 8.4 German Organ Physiological Microsystem Market
  • 8.5 French Organ Physiological Microsystem Market
  • 8.6 Spanish Organ Physiological Microsystem Market
  • 8.7 Italian Organ Physiological Microsystem Market
  • 8.8 United Kingdom Organ Physiological Microsystem Market

9. APAC Organ Physiological Microsystem Market

  • 9.1 Overview
  • 9.2 APAC Organ Physiological Microsystem Market by Type
  • 9.3 APAC Organ Physiological Microsystem Market by Application
  • 9.4 Japanese Organ Physiological Microsystem Market
  • 9.5 Indian Organ Physiological Microsystem Market
  • 9.6 Chinese Organ Physiological Microsystem Market
  • 9.7 South Korean Organ Physiological Microsystem Market
  • 9.8 Indonesian Organ Physiological Microsystem Market

10. ROW Organ Physiological Microsystem Market

  • 10.1 Overview
  • 10.2 ROW Organ Physiological Microsystem Market by Type
  • 10.3 ROW Organ Physiological Microsystem Market by Application
  • 10.4 Middle Eastern Organ Physiological Microsystem Market
  • 10.5 South American Organ Physiological Microsystem Market
  • 10.6 African Organ Physiological Microsystem Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Organ Physiological Microsystem Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Emulate
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Draper Laboratory
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Mimetas
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 TissUse
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 CN Bio
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Hesperos
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Nortis
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Micronit
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Kirkstall
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Bi/ond
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Organ Physiological Microsystem Market
  • Figure 2.1: Usage of Organ Physiological Microsystem Market
  • Figure 2.2: Classification of the Global Organ Physiological Microsystem Market
  • Figure 2.3: Supply Chain of the Global Organ Physiological Microsystem Market
  • Figure 3.1: Driver and Challenges of the Organ Physiological Microsystem Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Organ Physiological Microsystem Market ($B) by Type
  • Figure 4.3: Forecast for the Global Organ Physiological Microsystem Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Single-organ System in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Multi-organ System in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.1: Global Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Organ Physiological Microsystem Market ($B) by Application
  • Figure 5.3: Forecast for the Global Organ Physiological Microsystem Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 6.1: Trends of the Global Organ Physiological Microsystem Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Organ Physiological Microsystem Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.1: European Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 8.4: European Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.1: APAC Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.1: ROW Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Organ Physiological Microsystem Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Organ Physiological Microsystem Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Organ Physiological Microsystem Market by Type
  • Figure 12.2: Growth Opportunities for the Global Organ Physiological Microsystem Market by Application
  • Figure 12.3: Growth Opportunities for the Global Organ Physiological Microsystem Market by Region
  • Figure 12.4: Emerging Trends in the Global Organ Physiological Microsystem Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Organ Physiological Microsystem Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Organ Physiological Microsystem Market by Region
  • Table 1.3: Global Organ Physiological Microsystem Market Parameters and Attributes
  • Table 3.1: Trends of the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 3.2: Forecast for the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Organ Physiological Microsystem Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.4: Trends of Single-organ System in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.5: Forecast for Single-organ System in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.6: Trends of Multi-organ System in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.7: Forecast for Multi-organ System in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Organ Physiological Microsystem Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.4: Trends of Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.5: Forecast for Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.6: Trends of Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.7: Forecast for Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 7.1: Trends of the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.2: Forecast for the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Organ Physiological Microsystem Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Organ Physiological Microsystem Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Organ Physiological Microsystem Market (2019-2031)
  • Table 8.1: Trends of the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.2: Forecast for the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Organ Physiological Microsystem Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Organ Physiological Microsystem Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Organ Physiological Microsystem Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Organ Physiological Microsystem Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Organ Physiological Microsystem Market (2019-2031)
  • Table 9.1: Trends of the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.2: Forecast for the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Organ Physiological Microsystem Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Organ Physiological Microsystem Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Organ Physiological Microsystem Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Organ Physiological Microsystem Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Organ Physiological Microsystem Market (2019-2031)
  • Table 10.1: Trends of the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.2: Forecast for the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Organ Physiological Microsystem Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Organ Physiological Microsystem Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Organ Physiological Microsystem Market (2019-2031)
  • Table 11.1: Product Mapping of Organ Physiological Microsystem Suppliers Based on Segments
  • Table 11.2: Operational Integration of Organ Physiological Microsystem Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Organ Physiological Microsystem Revenue
  • Table 12.1: New Product Launches by Major Organ Physiological Microsystem Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Organ Physiological Microsystem Market